The last several years have seen the explosive growth of major new technologies some of which are a result of collaborative initiatives involving chemists, physicists, engineers, molecular geneticists as well as computer programmers and software developers. Many of these advances have resulted in start-up companies (Affymetrix, Inc., Caliper Technology Corporation, Genometrix, Inc., Nanogen, Inc., Synteni, Inc., etc) whose focus is to capitalize and expand on these technologies for commercial use. DNA 'chips', as they are commonly called, promise to facilitate cost-effective, parallel array processing for the purposes of mutation and polymorphism detection, definition of gene expression profiles, microsatellite genotyping, defining gene organization and mapping as well as DNA sequence analysis, to mention only a few potential uses.
Front-end microchip systems are being developed capable of isolating particular cells mechanically (eg human lymphocytes) or electronically (eg bacteria).
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The isolated cells can be used directly for PCR reaction (in the case of lymphocytes) or subjected to electronic lysis before PCR or other amplification technology is applied. 3, 4 The amplicons are then examined by chip capillary electrophoresis or other analyses on a chip. [5] [6] [7] Some of these approaches involve use of silicon-based technologies which have been previously confined to use in the semiconductor industry. 8 New materials like polycarbonate may soon expand the utility of this approach.
Protocols are available for precise deposition and/or synthesis of nuclei acids onto a microarray which can be the size of a computer chip. [9] [10] [11] These chips with bound probes can then be used for interrogation by labeled targets, which when annealed to their complementary matches, result in the in-place formation on a chip of hybrids which can be detected using highly sensitive sophisticated imaging systems.
Sensitivities approaching detection of 0.1 attomoles in a spot at a particular register on a chip have been reported. Non-chip based approaches are also being used (eg SAGE, differential displays, etc) to analyze gene expression profiles, and they promise to add to our knowledge of the regulated expression of genes in normal and diseased states. 12, 13 Initial reports also show the potential of 3D reconstruction of gene expression profiles in the developing human embryo.
14 Non-gel based approaches to DNA sequence analysis and microsatellite genotype analysis are also well along in development. Finally, new approaches using 2D gels and mass spectral analysis of derived peptides from the individual electropherogram spots hold promise for facilitating detailed information on protein expression patterns in a variety of different cells. 15 The European Journal of Human Genetics recognizes these highly promising newly emerging technologies and now solicits submission of original manuscripts detailing these new and other advances and their application to the study of human genetics.
